Dihexa
Preclinicalaka N-hexanoic-Tyr-Ile-(6) aminohexanoic amide
Angiotensin-IV-derived peptide that builds synapses, in rodents. Strong claims, early days.
Mechanism
Derived from angiotensin IV and studied for growing new synapses through the HGF/c-Met pathway. The preclinical potency numbers are eye-watering, which is exactly why you wait for human data before believing them.
Regulatory & Safety Status
Early research, not approved, basically no human data. This is a lab compound, not a stack staple.
Research
Hepatocyte Growth Factor/MET Activator Rescues Working Memory Deficits after Repeated Mild Traumatic Brain Injury
Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions
Effects of an Angiotensin IV Analog on 3-Nitropropionic Acid-Induced Huntington's Disease-Like Symptoms in Rats
Efficiently generate functional hepatic cells from human pluripotent stem cells by complete small-molecule strategy
Latest dihexa research